PEG as a safe alternative after BDDE-related delayed inflammatory reaction: a case report

REPORT summary

Patient

A patient with prior delayed inflammatory reaction to BDDE-based fillers requested HA treatment three years after resolution.

Results

A total of 2 ml was injected bilaterally into the lateral and mid-to-lower face using linear retrograde and fanning techniques. At 12-month follow-up, volume and skin quality were restored with no inflammatory recurrence.

Treatments

Neauvia Stimulate (PEG-crosslinked HA 26 mg/ml + 1% CaHA) was chosen for safety and dual volumizing/biostimulatory action.

Dr. Cosmina Sandor
Dermatologist
Romania

want to know more about
our treatments?

    Response channel: